At a glance
Sjögren disease is a chronic systemic autoimmune disease that primarily affects the tear and salivary glands.
Symptoms, severity, and organ involvement vary substantially, making a single typical course inadequate.
Disease Atlas / Disease detail
A structured view of systemic autoimmunity beyond dryness, covering diagnostic synthesis, variability, long-term care, and research.
Sjögren disease · Sjögren syndrome · Sjögren's disease
Start with the essentials, then explore the patient and research views.
Public revision · fbdac1a9cbab
A structured guide for understanding the disease and preparing for clinical conversations.
Sjögren disease is a chronic systemic autoimmune disease that primarily affects the tear and salivary glands.
Symptoms, severity, and organ involvement vary substantially, making a single typical course inadequate.
Lymphocytic inflammation and epithelial–immune interactions contribute to gland dysfunction and systemic manifestations.
Dry eyes and dry mouth are typical, while fatigue, joint pain, and pulmonary, renal, or neurologic involvement can also occur.
No single test establishes Sjögren disease; evaluation integrates history, examination, objective dryness tests, blood tests, and salivary-gland assessment when needed.
Autoantibodies such as anti-Ro/SSA can support diagnosis but do not alone determine disease presence or severity.
Management combines local relief of eye and mouth dryness, preventive dental and eye care, and therapy tailored to systemic involvement.
Systemic immunomodulatory treatment is individualized according to organ involvement, severity, comorbidity, and treatment risk.
Trial results should distinguish symptom improvement, objective gland function, and systemic disease activity endpoints.
Clinical discussions distinguish symptom priorities, objective test results, signs of systemic involvement, and treatment goals.
This material is for disease education and is not a personal diagnosis or treatment instruction.
A trial registry status does not establish efficacy or regulatory approval.
NIAMS · GOVERNMENT SUMMARY
NIDCR · GOVERNMENT SUMMARY
PubMed · GUIDELINE
Nature Reviews Rheumatology / PubMed · PEER REVIEWED REVIEW